Young-Onset Colorectal Cancer Dynamics

Colorectal cancer arising before age 50 has shown a worrying and sustained increase in incidence over recent decades, in contrast to falling rates in older adults. This young-onset group often presents with advanced-stage disease, aggressive histological features such as poor differentiation, signet ring cell or mucinous subtypes, and a predominance of distal-colon or rectal tumours. A substantial proportion lacks known hereditary syndromes or family history, highlighting the need to unravel environmental, metabolic and microbiome influences on tumour initiation. Molecular profiling indicates a predominance of microsatellite-stable but chromosomally unstable tumours, with lower frequencies of BRAF mutations and CpG island methylator phenotype compared with later-onset disease. Delays in diagnosis arise from low clinical suspicion and screening guidelines that exclude younger adults. The global rise in young-onset disease carries major implications for public health, screening policy, risk stratification and the development of targeted prevention and therapeutic strategies.

Research from Nature Portfolio

A large, multinational analysis of patients aged ≤50 from registries in China, the United States and Sweden has defined distinct clinicopathological patterns in young-onset colorectal cancer. Despite more advanced tumours and adverse features such as mucinous and signet ring cell differentiation, young patients demonstrated unexpectedly favourable cancer-specific survival compared with older cohorts after adjustment for stage and treatment. Crucially, the study identified several prognostic biomarkers including prolactin (PRL), RNA-binding motif protein 3 (RBM3), Wrap53, p53 expression and tumour DNA content, all of which showed significant associations with long-term outcomes. These findings support the incorporation of molecular markers into risk models and may guide personalised management in young adults.

Young-Onset Colorectal Cancer Dynamics publication trend

The graph below shows the total number of articles in young-onset colorectal cancer dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Microsatellite instability (MSI): a form of genetic hypermutability resulting from defective DNA mismatch repair mechanisms.

Chromosomal instability (CIN): a characteristic of tumours showing frequent gains or losses of whole chromosomes or large chromosomal segments.

Signet ring cell histology: a variant in which malignant cells contain abundant mucin that displaces the nucleus, resembling a signet ring.

Mucinous carcinoma: a tumour subtype rich in extracellular mucin, often associated with a distinct clinical course and response to therapy.

Prognostic biomarker: a measurable molecular or histological feature that provides information on the likely disease course or patient outcome.

References

1. Early‐onset colorectal cancer in young individuals. Molecular Oncology (2018).
2. Sporadic Early-Onset Colorectal Cancer Is a Specific Sub-Type of Cancer: A Morphological, Molecular and Genetics Study. PLOS ONE (2014).
3. Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review. BMC Cancer (2020).
4. Demographic trends in the incidence of young-onset colorectal cancer: a population-based study. British Journal of Surgery (2020).
5. The prognostic factors and multiple biomarkers in young patients with colorectal cancer. Scientific Reports (2015).
6. Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer Center. Cancers (2019).